Eosinophilic esophagitis (EoE) is a chronic immune-mediated disorder that affects the esophagus and can cause difficulty swallowing, chest pain, and food impaction. While there is no cure for EoE, there are several biologic medications that can help manage symptoms and improve quality of life for adults with the condition. Here are 10 adult biologics commonly used to treat EoE:

Benralizumab (Fasenra)
Dupilumab (Dupixent)
Mepolizumab (Nucala)
Reslizumab (Cinqair)
Omalizumab (Xolair)
Vedolizumab (Entyvio)
Secukinumab (Cosentyx)
Ustekinumab (Stelara)
Tocilizumab (Actemra)
Rituximab (Rituxan)

These biologics work by targeting specific proteins in the immune system that are involved in the inflammation and immune response seen in EoE. They are typically administered through injections or infusions and may be used alone or in combination with other medications to achieve the best possible outcomes for patients.

It is important for individuals with EoE to work closely with their healthcare providers to determine the most appropriate treatment plan for their specific needs. Biologics can be an effective option for managing symptoms and improving quality of life for adults with EoE, but they may not be suitable for everyone. It is essential to weigh the potential benefits and risks of biologic therapy with your healthcare team to make informed decisions about your treatment.

10 Adult Biologics for Eosinophilic Esophagitis